PALANDRI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 317
EU - Europa 174
AS - Asia 40
AF - Africa 1
Totale 532
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 316
IE - Irlanda 56
SE - Svezia 55
IT - Italia 30
HK - Hong Kong 16
CN - Cina 12
DE - Germania 10
CH - Svizzera 9
JO - Giordania 8
GB - Regno Unito 6
UA - Ucraina 5
TR - Turchia 4
FI - Finlandia 3
CA - Canada 1
SC - Seychelles 1
Totale 532
Salva come PNG Salva come JPEG
Città #
Chandler 78
Dublin 56
Altamura 24
Lawrence 24
Fairfield 18
Princeton 14
Ashburn 12
Cambridge 12
Boston 11
Beijing 10
Wilmington 10
Bern 9
Jacksonville 9
San Diego 9
Woodbridge 9
Medford 8
Buffalo 7
Seattle 7
Houston 6
Andover 4
Izmir 4
Ann Arbor 3
Boardman 3
Bremen 3
Hangzhou 2
London 2
Norwalk 2
Pistoia 2
San Mateo 2
Arnsberg 1
Falls Church 1
Fontevivo 1
Hillsboro 1
New Bedfont 1
Redmond 1
Rome 1
Toronto 1
Trumbull 1
Totale 369
Salva come PNG Salva come JPEG
Nome #
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B 2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 68
Total serum IgE levels influence the in vitro detection of ss-lactams-specific IgE antibodies 55
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 50
A modified adenine chemically coupled to the allergen molecule of Dermatophagoides pteronyssinus redirects allergen-specific Th2 cells 47
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 35
Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients 35
Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19 34
Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study 32
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 30
COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey 29
A modified adenine chemically coupled to allergen molecule(s) induce Interferon-gamma production and down regulate IL-4 and IL-5 in Th2 specific T cells 28
Long-term follow-up of recovered MPN patients with COVID-19 27
Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis 26
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib 22
null 15
MPN-375 BET Inhibitor Pelabresib (CPI-0610) Combined With Ruxolitinib in Patients With Myelofibrosis - JAK Inhibitor-Naïe or With Suboptimal Response to Ruxolitinib - Preliminary Data From the MANIFEST Study 5
Breakthrough infections in MPN-COVID vaccinated patients 5
Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT 3
Risk-adjusted safety analysis of the oral JAK2/IRAK1 inhibitor pacritinib in patients with myelofibrosis 2
MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis 2
Totale 550
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2.093
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.093
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 3 0 2 0 0 0 4 0
2019/202048 0 1 0 1 5 5 4 8 5 7 7 5
2020/202147 3 2 4 3 3 5 0 10 4 6 4 3
2021/202278 3 1 3 1 0 3 0 23 3 1 10 30
2022/2023323 24 73 20 17 23 45 36 21 38 6 8 12
2023/202438 5 14 19 0 0 0 0 0 0 0 0 0
Totale 550